Yeast identification in routine clinical microbiology laboratory and its clinical relevance

Agarwal, S.; Manchanda, V.; Verma, N.; Bhalla, P.
April 2011
Indian Journal of Medical Microbiology;Apr2011, Vol. 29 Issue 2, p172
Academic Journal
Rapid identification of yeast infections is helpful in prompt appropriate antifungal therapy. In the present study, the usefulness of chromogenic medium, slide culture technique and Vitek2 Compact (V2C) has been analysed. A total of 173 clinical isolates of yeast species were included in the study. An algorithm to identify such isolates in routine clinical microbiology laboratory was prepared and followed. Chromogenic medium was able to identify Candida albicans, C. tropicalis, C. krusei, C. parapsilosis and Trichosporon asahii. Chromogenic medium was also helpful in identifying "multi-species" yeast infections. The medium was unable to provide presumptive identification of C. pelliculosa, C. utilis, C. rugosa, C. glabrata and C. hemulonii. Vitek 2 compact (V2C) differentiated all pseudohypae non-producing yeast species. The algorithm followed was helpful in timely presumptive identifi cation and final diagnosis of yeast infections, including multi-species yeast infections.


Related Articles

  • International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia. Ostrosky-Zeichner, L.; Kontoyiannis, D.; Raffalli, J.; Mullane, K. M.; Vazquez, J.; Anaissie, E. J.; Lipton, J.; Jacobs, P.; Jansen van Rensburg, J. H.; Rex, J. H.; Lau, W.; Facklam, D.; Buell, D. N. // European Journal of Clinical Microbiology & Infectious Diseases;Oct2005, Vol. 24 Issue 10, p654 

    Candida spp. are the fourth leading cause of bloodstream infections, and non- albicans species are increasing in importance. Micafungin is a new echinocandin antifungal agent with excellent in vitro activity against Candida spp. Pediatric, neonatal, and adult patients with new or refractory...

  • MOLECULAR IDENTIFICATION OF CANDIDA SPECIES ISOLATED FROM ONYCHOMYCOSIS IN IRAN. Mohammadi, Rasoul; Mirhendi, Hossein; Ghahri, Mohammad; Yadegari, Mohammad Hossein; Shadzi, Shahla; Pourfathi, Parinaz; Jalalizand, Niloufar // Jundishapur Journal of Microbiology;2013 Special Edition, p73 

    Introduction and Objectives: Onychomycosis is a chronic fungal infection of nails caused by dermatophytes, yeasts and moulds. Nail infections caused by Candida species are normally associated with chronic paronychia or chronic mucocutaneous candidiasis. Onychomycosis due to Candida (candidal...

  • Efficacy of a Single Oral Dose of 200 mg Pramiconazole in Vulvovaginal Yeast Infections: An Exploratory Phase IIa Trial. Donders, Gilbert; Ausma, Jannie; Wouters, Luc; Cauwenbergh, Geert; Borgers, Marcel; Janssens, Dirk // Acta Dermato-Venereologica;2008, Vol. 88 Issue 5, p462 

    Pramiconazole (R126638) is a novel azole with potent antifungal activity against yeasts, dermatophytes and many other fungal species. The aim of this study was to evaluate the efficacy and tolerance of a single oral dose of 200 mg pramiconazole in acute and recurrent vulvo-vaginal yeast...

  • Minireview: Malassezia infections in immunocompromised patients.  // Journal of Invasive Fungal Infections;2010, Vol. 4 Issue 3, p117 

    Malassezia are opportunistic yeasts that can cause recurrent skin infections and invasive infections in the immunocompromised patient. The spectrum of infection ranges from very mild to life-threatening. Malassezia fungemia is usually associated with lipid-solution administration through venous...

  • clotrimazole. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p180 

    An encyclopedia entry for the term "clotrimazole" is presented. It refers to an antifungal drug that is used for the treatment of candidiasis, and other types of yeast and fungal infections.

  • Identification and Analysis of Cation Channel Homologues in Human Pathogenic Fungi. Prole, David L.; Taylor, Colin W.; Harris, Steven // PLoS ONE;Aug2012, Vol. 7 Issue 8, Special section p1 

    Fungi are major causes of human, animal and plant disease. Human fungal infections can be fatal, but there are limited options for therapy, and resistance to commonly used anti-fungal drugs is widespread. The genomes of many fungi have recently been sequenced, allowing identification of...

  • Efficacy of micafungin for the treatment of candidemia. Andes, D.; Safdar, N. // European Journal of Clinical Microbiology & Infectious Diseases;Oct2005, Vol. 24 Issue 10, p662 

    The article discusses a study, by L. Ostrosky-Zeichner and colleagues, which evaluates the efficacy of antifungal micafungin for the treatment of candidemia. The authors reported an overall successful response to micafungin in 83.9 percent of participants in the study. The findings effectively...

  • Caspofungin.  // Reactions Weekly;2/19/2011, Issue 1339, p15 

    The article describes the cases of two patients who developed pulmonary infections caused by Hormographiella aspergillata while undergoing caspofungin treatment for presumed fungal pneumonia.

  • A Study for Testing the Antifungal Susceptibility of Yeast by the Japanese Society for Medical Mycology (JSMM) Method - The Proposal of the Modified JSMM Method 2009. Nishiyama, Yayoi; Abe, Michiko; Ikeda, Reiko; Uno, Jun; Oguri, Toyoko; Shibuya, Kazutoshi; Maesaki, Shigefumi; Mohri, Shinobu; Yamada, Tsuyoshi; Ishibashi, Hiroko; Hasumi, Yayoi; Abe, Shigeru // Japanese Journal of Medical Mycology;Sep2010, Vol. 51 Issue 3, p153 

    The Japanese Society for Medical Mycology (JSMM) method used for testing the antifungal susceptibility of yeast. the MIC end point for azole antifungal agents, is currently set at IC80. It was recently shown, however that there is an inconsistency in the MIC value between the JSMM method and the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics